| scholarly article | Q13442814 |
| P50 | author | Mary Beth Beasley | Q109162989 |
| R. Graham Barr | Q110621772 | ||
| David C. Christiani | Q30069760 | ||
| P2093 | author name string | Charles A Powell | |
| Kevin K Brown | |||
| Yoshikazu Inoue | |||
| Christopher J Ryerson | |||
| Athol U Wells | |||
| David A Lynch | |||
| Luca Richeldi | |||
| Andrew G Nicholson | |||
| Johny Verschakelen | |||
| John H M Austin | |||
| Jin Mo Goo | |||
| Hiroto Hatabu | |||
| Martine Remy-Jardin | |||
| Gary M Hunninghake | |||
| Nicola Sverzellati | |||
| Joon Beom Seo | |||
| Raúl San José Estépar | |||
| Takeshi Johkoh | |||
| Kyung Soo Lee | |||
| P2860 | cites work | Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality | Q96111262 |
| Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis | Q28240230 | ||
| A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis | Q28240241 | ||
| An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias | Q28298430 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis | Q28943334 | ||
| Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study | Q28943525 | ||
| Telomerase mutations in families with idiopathic pulmonary fibrosis | Q29615671 | ||
| Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia | Q30388977 | ||
| Building a reference multimedia database for interstitial lung diseases. | Q33976198 | ||
| Smoking-related interstitial lung diseases: a concise review | Q34222060 | ||
| Lung volumes and emphysema in smokers with interstitial lung abnormalities | Q34781472 | ||
| Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. | Q35153490 | ||
| Smoking-related idiopathic interstitial pneumonia | Q35195530 | ||
| Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations | Q35201853 | ||
| Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival. | Q35418456 | ||
| The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. | Q35557834 | ||
| A comparison of visual and quantitative methods to identify interstitial lung abnormalities | Q35826595 | ||
| Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking | Q35872005 | ||
| Interstitial lung abnormalities and reduced exercise capacity | Q35889148 | ||
| Early interstitial lung disease in familial pulmonary fibrosis | Q36013730 | ||
| Subclinical interstitial lung disease: why you should care | Q36026274 | ||
| A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
| Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up. | Q36368857 | ||
| Association Between Interstitial Lung Abnormalities and All-Cause Mortality | Q36790758 | ||
| Telomere shortening in familial and sporadic pulmonary fibrosis | Q36915503 | ||
| Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate | Q37039525 | ||
| Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens | Q37078808 | ||
| MUC5B promoter polymorphism and interstitial lung abnormalities | Q37105760 | ||
| Feasibility of automated quantification of regional disease patterns depicted on high-resolution computed tomography in patients with various diffuse lung diseases. | Q37318365 | ||
| Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. | Q37343777 | ||
| Quantitative computed tomography imaging of interstitial lung diseases | Q37363128 | ||
| Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old. | Q37463682 | ||
| Identification of early interstitial lung disease in smokers from the COPDGene Study | Q37466106 | ||
| Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis | Q38751135 | ||
| Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. | Q38785085 | ||
| An Ensemble Method for Classifying Regional Disease Patterns of Diffuse Interstitial Lung Disease Using HRCT Images from Different Vendors | Q38948833 | ||
| Multi-source Transfer Learning with Convolutional Neural Networks for Lung Pattern Analysis | Q39004358 | ||
| Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. | Q39675660 | ||
| Occupational Exposures and Subclinical Interstitial Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Air- Lung Study. | Q40104303 | ||
| High Attenuation Areas on Chest CT and Clinical Respiratory Outcomes in Community-dwelling Adults. | Q40160454 | ||
| The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers | Q40419340 | ||
| High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. | Q40502107 | ||
| Asbestos-related pleural and parenchymal fibrosis: detection with high-resolution CT. | Q42517891 | ||
| Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. | Q46125322 | ||
| Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group | Q47102520 | ||
| The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes | Q47124422 | ||
| Comparison of Shallow and Deep Learning Methods on Classifying the Regional Pattern of Diffuse Lung Disease. | Q47434473 | ||
| Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study | Q47687005 | ||
| Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. | Q47706610 | ||
| Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial | Q47915121 | ||
| Interstitial Lung Abnormalities Are Associated with Acute Respiratory Distress Syndrome. | Q48008902 | ||
| Toward Early Identification of Clinically Relevant Interstitial Lung Disease | Q48088026 | ||
| Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections. | Q49961512 | ||
| Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis. | Q50002647 | ||
| Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. | Q50015039 | ||
| Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. | Q51659099 | ||
| Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically. | Q53156466 | ||
| Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? | Q53423949 | ||
| Texture-Based Automated Quantitative Assessment of Regional Patterns on Initial CT in Patients With Idiopathic Pulmonary Fibrosis: Relationship to Decline in Forced Vital Capacity. | Q53926010 | ||
| Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy. | Q55079973 | ||
| A Review of Smoking-Related Interstitial Fibrosis, Respiratory Bronchiolitis, and Desquamative Interstitial Pneumonia: Overlapping Histology and Confusing Terminology | Q57052169 | ||
| Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis: The Future of Quantitative Analysis | Q57176689 | ||
| Interstitial lung diseases in a lung cancer screening trial | Q57559323 | ||
| Interstitial lung abnormalities are associated with increased mortality in smokers | Q57640595 | ||
| Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease | Q64005207 | ||
| Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome | Q64101872 | ||
| Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests | Q70520803 | ||
| Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations | Q70553649 | ||
| Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage | Q72822445 | ||
| American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) | Q73445075 | ||
| Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests | Q77388173 | ||
| Interstitial lung disease: A quantitative study using the adaptive multiple feature method | Q77932763 | ||
| Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal | Q80210080 | ||
| Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens | Q82219022 | ||
| Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course | Q83056870 | ||
| The radiological patterns of interstitial change at an early phase: over a 4-year follow-up | Q84385516 | ||
| Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis | Q85960673 | ||
| Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography | Q87909968 | ||
| Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement | Q88235643 | ||
| MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis | Q90316654 | ||
| Nintedanib in Progressive Fibrosing Interstitial Lung Diseases | Q90362915 | ||
| Interstitial Lung Abnormality: Recognition and Perspectives | Q90608355 | ||
| Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions | Q91111936 | ||
| Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality | Q91181067 | ||
| Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline | Q91247291 | ||
| Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer | Q91614581 | ||
| Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program | Q91681521 | ||
| Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis | Q92144259 | ||
| Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study | Q92482422 | ||
| Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival | Q92509924 | ||
| Classification of Interstitial Lung Abnormality Patterns with an Ensemble of Deep Convolutional Neural Networks | Q92668917 | ||
| Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics | Q92698491 | ||
| Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal | Q93075324 | ||
| Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer | Q93086041 | ||
| P6195 | funding scheme | grant | Q230788 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | screening | Q1163564 |
| lung disease | Q3392853 | ||
| lung cancer | Q47912 | ||
| P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
| P304 | page(s) | 726-737 | |
| P12526 | performing organization | Harvard University | Q13371 |
| P577 | publication date | 2020-07-01 | |
| P1433 | published in | The Lancet. Respiratory medicine | Q27724908 |
| P859 | sponsor | National Institute for Occupational Safety and Health | Q60346 |
| P1476 | title | Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society | |
| P478 | volume | 8 |
Search more.